Molecule Information
General Information of the Molecule (ID: Mol02182)
Name |
GABPB1 antisense RNA 1 (GABPB1-AS1)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
GABPB1-AS1
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
GABPB1-AS1
|
||||
Gene ID | |||||
Ensembl ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Patented Agent(s)
1 drug(s) in total
Erastin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Cholangiocarcinoma | [1] | |||
Resistant Disease | Cholangiocarcinoma [ICD-11: 2C12.0] | |||
Resistant Drug | Erastin | |||
Molecule Alteration | Down-regulation | Interaction |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | HepG2 cells | Liver | Homo sapiens (Human) | CVCL_0027 |
Hep3B cells | Liver | Homo sapiens (Human) | CVCL_0326 | |
Huh7 cells | Kidney | Homo sapiens (Human) | CVCL_U442 | |
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells. |
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
Liver cancer [ICD-11: 2C12]
Differential expression of molecule in resistant diseases | ||
The Studied Tissue | Bile duct | |
The Specified Disease | Cholangiocarcinoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.56E-02; Fold-change: -9.63E-02 | |
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Liver | |
The Specified Disease | Liver hepatocellular carcinoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.51E-01; Fold-change: -9.41E-03 | |
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
Disease-specific Molecule Abundances | Click to View the Clearer Original Diagram | |
Tissue-specific Molecule Abundances in Healthy Individuals
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.